A DNA damage checkpoint response in telomere-initiated senescence

Nature

Volumn 426, Issue 6963, 2003, Pages 194-198

  D'Adda Di Fagagna, Fabrizio ^a,d   Reaper, Philip M ^a   Clay Farrace, Lorena ^a   Fiegler, Heike ^b   Carr, Philippa ^b   Von Zglinicki, Thomas ^c   Saretzki, Gabriele ^c   Carter, Nigel P ^b   Jackson, Stephen P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENZYMES; IMMUNOLOGY; PRECIPITATION (CHEMICAL);

FIBROBLASTS; SOMATIC CELLS;

CHROMOSOMES;

CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; DOUBLE STRANDED DNA; HISTONE H2A; HISTONE H2AX; MOLECULAR MARKER; NIBRIN; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN 53BP1; PROTEIN MDC1; UNCLASSIFIED DRUG;

DNA;

ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL NUCLEUS; CHROMATIN; CHROMOSOME; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME INACTIVATION; FIBROBLAST; GENOME ANALYSIS; GENOMICS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SENESCENCE; TELOMERE;

CARRIER PROTEINS; CELL AGING; CELL CYCLE; CELL CYCLE PROTEINS; CHROMATIN; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FIBROBLASTS; HISTONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; S PHASE; TELOMERE; TRANS-ACTIVATORS;

EID: 0344441890     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02118     Document Type: Article

References (30)

1. Hayflick, L. & Moorhead, P. S. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 25, 585-621 (1961).
2. Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells, Science 279, 349-352 (1998).
3. Shiloh, Y. ATM and related protein kinases: safeguarding genome integrity. Nature Rev. Cancer 3, 155-168 (2003).
4. Nyberg, K. A., Michelson, R. J., Putnam, C. W. & Weinert, T. A. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 36, 617-656 (2002).
5. Lou, Z., Minter-Dykhouse, K., Wu, X. & Chen, J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 421, 957-961 (2003).
6. Stewart, G. S., Wang, B., Bignell, C. R., Taylor, A. M. R. & Elledge, S. J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421, 961-966 (2003).
7. Goldberg, M. et al. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421, 952-956 (2003).
8. Webley, K. et al. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol. Cell. Biol. 20, 2803-2808 (2000).
9. de Lange, T. Protection of mammalian telomeres. Oncogene 21, 532-540 (2002).
10. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. & de Lange, T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325 (1999).
11. Smogorzewska, A. & De Lange, T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21, 4338-4348 (2002).
12. Martens, U. M. et al. Short telomeres on human chromosome 17p. Nature Genet. 18, 76-80 (1998).
13. van Steensel, B., Smogorzewska, A. & de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401-413 (1998).
14. + and Saccharomyces cerevisiae RAD17: linkage to checkpoint control and mammalian meiosis. Genes Dev. 12, 2560-2573 (1998).
15. Lukas, C., Falck, J., Bartkova, J., Bartek, J. & Lukas, J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nature Cell Biol. 5, 255-260 (2003).
16. Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (1998).
17. Cliby, W. A. et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17, 159-169 (1998).
18. Heffernan, T. P. et al. An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage. Mol. Cell. Biol. 22, 8552-8561 (2002).
19. Chehab, N. H., Malikzay, A., Appel, M. & Halazonetis, T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14, 278-288 (2000).
20. Stoeber, K. et al. DNA replication licensing and human cell proliferation. J. Cell Sci. 114, 2027-2041 (2001).
21. Schmitt, C. A. Senescence, apoptosis and therapy-cutting the lifelines of cancer. Nature Rev. Cancer 3, 286-295 (2003).
22. Parrinello, S. et al. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nature Cell Biol. 5, 741-747 (2003).
23. Wong, K. K. et al. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nature Genet. 26, 85-88 (2000).
24. Goytisolo, F. A. et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J. Exp. Med. 192, 1625-1636 (2000).
25. Campisi, J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11, S27-S31 (2001).
26. Hoeijmakers, J. H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374 (2001).
27. d'Adda di Fagagna, F. et al. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11, 1192-1196 (2001).
28. Fiegler, H. et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosom. Cancer 36, 361-374 (2003).
29. Zhao, H., Watkins, J. L. & Piwnica-Worms, H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl Acad. Sci. USA 99, 14795-14800 (2002).
30. Sorensen, C. S. et al. Chk1 regulares the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3, 247-258 (2003).